Menu

Category

All
  • ASCO 2020
  • ASCO 2021
  • Clinical trials
  • Congress news
  • PODCASTS
  • UPDATE adrenal cell carcinoma
  • UPDATE CRC

Tumortype

All
  • adrenal cell carcinoma
  • breast cancer
  • Gastrointestinal cancer
  • Gynaecological cancer
  • Head and Neck cancer
  • Lung cancer
  • Skin cancer

Year

All
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
SUBSCRIBE TO BJMO ONCOTALKS SERIES

All podcasts

August 2022

New Belgian clinical practice guidelines for the treatment of patients with HER2-positive advanced breast cancer
Prof. Evandro De Azambuja, Institut Jules Bordet
June 2022
Congress news 

Dr. Kevin Punie talks us through some of the key ASCO 2022 data in the field of breast cancer
Dr. Kevin Punie, University Hospitals Leuven
June 2022
Congress news 

Prof. Dr. Hans Prenen shares his ASCO 2022 highlights in the field of gastro-intestinal cancer
Prof. Dr. Hans Prenen, University Hospital Antwerp
June 2022
Congress news 

Dr. Willem Lybaert discusses some of the key ASCO 2022 data in the field of head and neck cancer
Dr. Willem Lybaert, AZ Nikolaas, Sint-Niklaas
June 2022
Congress news 

Prof. Dr. Lore Decoster will walk us through the ASCO 2022 highlights in thoracic oncology
Prof. Dr. Lore Decoster, University Hospital Brussels
June 2022
Congress news 

Dr. Daan De Maeseneer will share his ASCO 2022 highlights in the field of urogenital cancer
Dr. Daan De Maeseneer, AZ Sint-Lucas, Bruges
June 2022
Congress news 

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma
Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium
June 2022
Congress news 

Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients
Prof. Dr. Christopher Hoeller, Medical University of Vienna, Vienna, Austria
June 2022
Congress news 

Prof. Nikkels on the TELESPOT Project: a Belgian teledermoscopy system in primary healthcare centres for early detection of skin cancer
Prof. Dr. Arjen Nikkels, CHU de Liège, Liège, Belgium
October 2021
Congress news 

Prof. Dr. Marc Van den Eynde about the results of the PRECONNECT study
Prof. dr. Marc Van den Eynde, digestive oncologist at the Clinique Universitaires Saint-Luc in Brussels
Top